GB0211377D0 - Medicament - Google Patents

Medicament

Info

Publication number: GB0211377D0
Authority: GB; United Kingdom
Prior art keywords: medicament
Prior art date: 2002-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0211377A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fusion Antibodies Ltd

Original Assignee

Fusion Antibodies Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-17

Filing date

2002-05-17

Publication date

2002-06-26

2002-05-17 Application filed by Fusion Antibodies Ltd filed Critical Fusion Antibodies Ltd

2002-05-17 Priority to GB0211377A priority Critical patent/GB0211377D0/en

2002-06-26 Publication of GB0211377D0 publication Critical patent/GB0211377D0/en

2003-05-16 Priority to US10/514,604 priority patent/US20060083738A1/en

2003-05-16 Priority to PCT/GB2003/002109 priority patent/WO2003097698A1/en

2003-05-16 Priority to CA002511604A priority patent/CA2511604A1/en

2003-05-16 Priority to AU2003234003A priority patent/AU2003234003A1/en

2003-05-16 Priority to EP03727673A priority patent/EP1506237A1/en

Status Ceased legal-status Critical Current

Links

GB0211377A 2002-05-17 2002-05-17 Medicament Ceased GB0211377D0 (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GB0211377A GB0211377D0 (en)	2002-05-17	2002-05-17	Medicament
US10/514,604 US20060083738A1 (en)	2002-05-17	2003-05-16	Treatment of cancer by the use of anti fas antibody
PCT/GB2003/002109 WO2003097698A1 (en)	2002-05-17	2003-05-16	Treatment of cancer by the use of anti fas antibody
CA002511604A CA2511604A1 (en)	2002-05-17	2003-05-16	Treatment of cancer by the use of anti fas antibody
AU2003234003A AU2003234003A1 (en)	2002-05-17	2003-05-16	Treatment of cancer by the use of anti fas antibody
EP03727673A EP1506237A1 (en)	2002-05-17	2003-05-16	Treatment of cancer by the use of anti fas antibody

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0211377A GB0211377D0 (en)	2002-05-17	2002-05-17	Medicament

Publications (1)

Publication Number	Publication Date
GB0211377D0 true GB0211377D0 (en)	2002-06-26

Family

ID=9936902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0211377A Ceased GB0211377D0 (en)	2002-05-17	2002-05-17	Medicament

Country Status (1)

Country	Link
GB (1)	GB0211377D0 (en)

2002
- 2002-05-17 GB GB0211377A patent/GB0211377D0/en not_active Ceased

Similar Documents

Publication	Publication Date	Title
GB0217225D0 (en)	2002-09-04	Medicinal compounds
GB0225540D0 (en)	2002-12-11	Medicinal compounds
GB0204719D0 (en)	2002-04-17	Medicinal compounds
GB0225535D0 (en)	2002-12-11	Medicinal compounds
GB0220730D0 (en)	2002-10-16	Medicinal compounds
GB0225030D0 (en)	2002-12-04	Medicinal compounds
AU2003259457A8 (en)	2004-04-30	Auto-destructible syringe
GB0206861D0 (en)	2002-05-01	Medicaments
GB0211578D0 (en)	2002-06-26	Medicaments
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
GB0308968D0 (en)	2003-05-28	Medicaments
GB0314733D0 (en)	2003-07-30	Medicaments
GB0217285D0 (en)	2002-09-04	Syringes
PL373409A1 (en)	2005-08-22	Pharmaceutical combination
GB0201520D0 (en)	2002-03-13	Pharmaceutical uses
GB0214885D0 (en)	2002-08-07	Medicament
GB0211377D0 (en)	2002-06-26	Medicament
GB0327913D0 (en)	2004-01-07	Medicament
GB0327912D0 (en)	2004-01-07	Medicament
GB0301842D0 (en)	2003-02-26	Medicament
GB0225206D0 (en)	2002-12-11	Medicaments
GB0215395D0 (en)	2002-08-14	Medicaments
GB0219241D0 (en)	2002-09-25	Medicaments
GB0210240D0 (en)	2002-06-12	Pharmaceutical combination
GB0217286D0 (en)	2002-09-04	Syringes

Legal Events

Date	Code	Title	Description
2003-08-13	AT	Applications terminated before publication under section 16(1)